Literature DB >> 1501115

Cardiovascular effects of cocaine in conscious rats: relative significance of central sympathetic stimulation and peripheral neuronal monoamine uptake and release mechanisms.

S R Tella1, C W Schindler, S R Goldberg.   

Abstract

Cocaine (0.03-3 mg/kg, i.v.) produced a dose-dependent increase in mean arterial blood pressure and heart rate in conscious Sprague-Dawley rats. Pretreatment with the competitive ganglionic blockers pentolinium or hexamethonium attenuated cocaine's pressor effect, whereas noncompetitive (chlorisondamine) or mixed (mecamylamine) type blockers not only abolished, but also reversed it to a depressor effect. Cocaine's tachycardiac effect was attenuated by all four ganglionic blockers. The relative effectiveness of the four ganglionic blockers in antagonizing cocaine-induced cardiovascular effects was similar to that of antagonism of phenylephrine-induced, centrally mediated reflex bradycardia. All four ganglionic blockers at all the doses tested produced similar reductions in base-line BP, thereby suggesting that these agents produced similar degrees of maximal reduction of basal sympathetic tone. The pressor responses to norepinephrine (0.2 micrograms/kg) were potentiated, whereas those to tyramine (0.3 mg/kg) were inhibited by cocaine (0.3-3 mg/kg); the former effect was not dose dependent (bell-shaped dose-response curve), whereas the latter effect was dose-dependent. The amine uptake inhibitory potency (ED50, 0.85 mg/kg) of cocaine is about 10 times less than its potency to produce pressor (ED50, 0.075 mg/kg) and tachycardiac (ED50, 0.083 mg/kg) effects. Chlorisondamine did not antagonize the pressor effects of the indirect sympathomimetic agent, tyramine. These results suggest that the blockade of cocaine's pressor and tachycardiac effects by ganglionic blockers is not related to their ability to eliminate basal sympathetic tone and, thereby, indirectly blunt cocaine's inhibitory effect on sympathetic neuronal uptake of norepinephrine. Rather, the results indicate that these effects are mainly due to their antagonistic actions on cocaine-induced central stimulation of sympathetic activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1501115

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Methiopropamine and its acute behavioral effects in mice: is there a gray zone in new psychoactive substances users?

Authors:  Fabio De-Giorgio; Sabrine Bilel; Micaela Tirri; Raffaella Arfè; Claudio Trapella; Cristian Camuto; Federica Foti; Paolo Frisoni; Margherita Neri; Francesco Botrè; Matteo Marti
Journal:  Int J Legal Med       Date:  2020-05-01       Impact factor: 2.686

2.  Amelioration of the cardiovascular effects of cocaine in rhesus monkeys by a long-acting mutant form of cocaine esterase.

Authors:  Gregory T Collins; Kathy A Carey; Diwahar Narasimhan; Joseph Nichols; Aaron A Berlin; Nicholas W Lukacs; Roger K Sunahara; James H Woods; Mei-Chuan Ko
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

3.  A case of cocaine-induced myopathy.

Authors:  Vithyalakshmi Selvaraj; Lakshmi Rani Gollamudi; Ashish Sharma; Jayakrishna Madabushi
Journal:  Prim Care Companion CNS Disord       Date:  2013-05-02

4.  Effects of a long-acting mutant bacterial cocaine esterase on acute cocaine toxicity in rats.

Authors:  Gregory T Collins; Matthew E Zaks; Alyssa R Cunningham; Carley St Clair; Joseph Nichols; Diwahar Narasimhan; Mei-Chuan Ko; Roger K Sunahara; James H Woods
Journal:  Drug Alcohol Depend       Date:  2011-04-11       Impact factor: 4.492

5.  Antiandrogen pretreatment alters cocaine pharmacokinetics in men.

Authors:  Rinah T Yamamoto; Christian J Teter; Tanya L Barros; Elissa McCarthy; Crystal Mileti; Trisha Juliano; Carissa L Medeiros; Alison Looby; Melissa A Maywalt; Jane F McNeil; David Olson; Gopinath Mallya; Scott E Lukas; Perry F Renshaw; Marc J Kaufman
Journal:  J Addict Med       Date:  2007-12       Impact factor: 3.702

6.  Different methods of assessing nicotine-induced antinociception may engage different neural mechanisms.

Authors:  A R Caggiula; L H Epstein; K A Perkins; S Saylor
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

7.  Phenotypic effects of chronic and acute use of methiopropamine in a mouse model.

Authors:  Federica Foti; Matteo Marti; Andrea Ossato; Sabrine Bilel; Eugenio Sangiorgi; Francesco Botrè; Bruna Cerbelli; Alfonso Baldi; Fabio De-Giorgio
Journal:  Int J Legal Med       Date:  2018-07-28       Impact factor: 2.686

8.  Enhanced neuronal and blunted hemodynamic reactivity to cocaine in the prefrontal cortex following extended cocaine access: optical imaging study in anesthetized rats.

Authors:  Craig P Allen; Kicheon Park; Ang Li; Nora D Volkow; George F Koob; Yingtian Pan; Xiu-Ti Hu; Congwu Du
Journal:  Addict Biol       Date:  2018-03-05       Impact factor: 4.280

9.  Nicotine's enhancing effects on responding maintained by conditioned reinforcers are reduced by pretreatment with mecamylamine, but not hexamethonium, in rats.

Authors:  Jeb Jones; Bethany R Raiff; Jesse Dallery
Journal:  Exp Clin Psychopharmacol       Date:  2010-08       Impact factor: 3.157

10.  Patterns of functional activity associated with cocaine self-administration in the rat change over time.

Authors:  Darrel J Macey; Wendy N Rice; Cory S Freedland; Christopher T Whitlow; Linda J Porrino
Journal:  Psychopharmacology (Berl)       Date:  2003-12-11       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.